This protocol is judged by an institutional evaluation board, an unbiased team that opinions any clinical trials involving human beings. If a study will involve a Plan I drug, as soon as the board approves the protocol as ethical, the scientists must submit an application for an investigational new drug (IND) number in the FDA.And For the reason th